ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
23andMe Holding Company

23andMe Holding Company (ME)

2.75
-0.11
(-3.85%)
Cerrado 04 Febrero 3:00PM
2.75
0.00
( 0.00% )
Pre Mercado: 3:01AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
2.75
Postura de Compra
2.70
Postura de Venta
3.49
Volume Operado de la Acción
1
0.00 Rango del Día 0.00
2.655 Rango de 52 semanas 16.52
Capitalización de Mercado [m]
Precio Anterior
2.75
Precio de Apertura
-
Última hora de negociación
04:50:35
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
328,492
Acciones en circulación
26,117,997
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.11
Beneficio por acción (BPA)
-25.53
turnover
219.64M
Beneficio neto
-666.7M

Acerca de 23andMe Holding Company

23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic t... 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. More than 80% of 23andMe customers voluntarily elect to share their de-identified genetic data with the company, which is used to develop future reports. In 2018, GlaxoSmithKline made an equity investment in the company, entering a five-year collaborative agreement with 23andMe to develop drug candidates. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Blank Checks
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
2021
23andMe Holding Company is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ME. The last closing price for 23andMe was US$2.75. Over the last year, 23andMe shares have traded in a share price range of US$ 2.655 to US$ 16.52.

23andMe currently has 26,117,997 shares in issue. The market capitalisation of 23andMe is US$71.82 million. 23andMe has a price to earnings ratio (PE ratio) of -0.11.

ME Últimas noticias

23andMe Launches New Genetic Report on Osteoporosis

SUNNYVALE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help people access, understand, and benefit from the...

23andMe Special Committee Announces Exploration of Strategic Alternatives

SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) (“23andMe” or the “Company”), a leading human genetics...

23andMe Reports Third Quarter Fiscal Year 2025 Financial Results

Company Notes Continued Concerns Regarding Liquidity and Consideration of Potential Ways to Address Operational and Financial Challenges SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE...

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, today announced the launch of Discover23®, a new research...

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

SUNNYVALE, Calif. and SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, and Mirador Therapeutics, a...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.56-16.9184290033.313.582.682378472.96551258CS
4-1.21-30.55555555563.964.182.682012903.39364387CS
12-1.78-39.2935982344.534.682.6553284923.38242355CS
26-4.85-63.81578947377.67.882.65515526316.18091085CS
52-11.77-81.060606060614.5216.522.65535340799.61004485CS
156-92.05-97.099156118194.8126.22.655335998233.38091742CS
260-129.05-97.9135053111131.8273.62.655269397952.52675075CS

ME - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de 23andMe?
El precio actual de las acciones de 23andMe es US$ 2.75
¿Cuántas acciones de 23andMe están en circulación?
23andMe tiene 26,117,997 acciones en circulación
¿Cuál es la capitalización de mercado de 23andMe?
La capitalización de mercado de 23andMe es USD 71.82M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de 23andMe?
23andMe ha negociado en un rango de US$ 2.655 a US$ 16.52 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de 23andMe?
El ratio precio/beneficio de 23andMe es -0.11
¿Cuál es el ratio de efectivo a ventas de 23andMe?
El ratio de efectivo a ventas de 23andMe es 0.33
¿Cuál es la moneda de reporte de 23andMe?
23andMe presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de 23andMe?
El último ingresos anual de 23andMe es USD 219.64M
¿Cuál es el último beneficio anual de 23andMe?
El último beneficio anual de 23andMe es USD -666.7M
¿Cuál es la dirección registrada de 23andMe?
La dirección registrada de 23andMe es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de 23andMe?
La dirección del sitio web de 23andMe es www.23andme.com
¿En qué sector industrial opera 23andMe?
23andMe opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
OPOFOld Point Financial Corporation
US$ 39.51
(58.99%)
4
TWINTwin Disc Inc
US$ 17.88
(58.93%)
169
IBACIB Acquisition Corporation
US$ 16.24
(58.90%)
62
ADSEADD TEC Energy PLC
US$ 23.39
(56.66%)
12
AFRIForafric Global PLC
US$ 14.99
(56.15%)
20
SBFGSB Finanical Group Inc
US$ 12.22
(-46.85%)
10
THRYThryv Holdings Inc
US$ 10.01
(-46.01%)
4
AURAAura Biosciences Inc
US$ 5.01
(-37.38%)
1
LSBKLake Shore Bancorp Inc
US$ 11.01
(-30.23%)
1
INBXInhibrx Biosciences Inc
US$ 9.01
(-30.21%)
30
SXTP60 Degrees Pharmaceuticals Inc
US$ 0.821
(37.52%)
20.72M
CYNCYNGN Inc
US$ 0.0798
(12.39%)
17.78M
UPCUniverse Pharmaceuticals Inc
US$ 0.341
(26.34%)
10.09M
ASSTAsset Entities Inc
US$ 0.7032
(28.02%)
8M
SFHGSamfine Creation Holdings Group Ltd
US$ 1.47
(47.00%)
7.48M

ME Discussion

Ver más
Banjo50 Banjo50 2 meses hace
I think it should be five cents. I bid five cents EACH FOR 1,000 SHARES!!!
👍️0
Monksdream Monksdream 4 meses hace
ME new 52 weeek low
👍️0
Monksdream Monksdream 4 meses hace
ME new 52 week
👍️0
Monksdream Monksdream 4 meses hace
ME new 52 week
👍️0
Pisd Pisd 5 meses hace
Independent Directors of 23andMe Resign from Board
September 17 2024 - 4:26PM


The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, in which the independent directors have provided their resignation from the Board, effective immediately:

Dear Anne,

We, the independent directors of the 23andMe Board, hereby tender our resignations, effective immediately.

After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders. We believe the Special Committee and the Board have provided ample time for you to submit such a proposal. That we have not seen any notable progress over the last 5 months leads us to believe no such proposal is forthcoming. The Special Committee is therefore unwilling to consider further extensions, and the Board agrees with the Special Committee’s determination.

While we continue to wholeheartedly support the Company’s mission and believe deeply in the value of the personalized health and wellness offering that you have articulated, it is also clear that we differ on the strategic direction for the Company going forward. Because of that difference and because of your concentrated voting power, we believe that it is in the best interests of the Company’s shareholders that we resign from the Board rather than have a protracted and distracting difference of view with you as to the direction of the Company.

We are proud of what 23andMe has achieved in pioneering direct access to genetic information, and we have been honored to have had the opportunity to be part of those efforts.

Sincerely,

/s/

Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice M.D., Richard Scheller, Ph.D., Peter J. Taylor

About 23andMe

23andMe is a genetics-led consumer healthcare and biopharmaceutical company empowering a healthier future. For more information, please visit www.23andMe.com.
👍️0
Pisd Pisd 5 meses hace
..coulda woulda shoulda, run into the ground..too bad ...
👍️0
Banjo50 Banjo50 5 meses hace
IS THIS STOCK A SCAM OR WHAT??? I WHAT THE TRUTH!!!
👍️0
BLACKBIRDSR-71 BLACKBIRDSR-71 5 meses hace
FOXO EPIGENETICS AI LOW FLOATER IS THE KEYS TO AI
👍️0
Monksdream Monksdream 6 meses hace
ME new 52 low
👍️0
Monksdream Monksdream 6 meses hace
ME new 52 low
👍️0
Pisd Pisd 9 meses hace
Data on the dark web no less, useless ...
👍️0
Afterhoursearnings3 Afterhoursearnings3 9 meses hace
Not great, but that's part of the game friend. Sometimes you lose.
👍️0
Pisd Pisd 10 meses hace
..only $170M market cap, sell to highest bidder! ME$$,,,
👍️0
Pisd Pisd 10 meses hace
AI, law enforcement/gov, pharma want ME dna database imo...
👍️0
ErnieBilco ErnieBilco 10 meses hace
Corporate theft IMO. The CEO and her board of minions should be excluded from any voting on this.
👍️0
Pisd Pisd 10 meses hace
Let insiders take private?, voting NO here...
👍️0
PapaSizz PapaSizz 10 meses hace
How'd that work out?
👍️0
Monksdream Monksdream 10 meses hace
It doesn’t bother me, since I have lots of money to buy shares of a company like Curtis-Wright
👍️0
ErnieBilco ErnieBilco 10 meses hace
Kathy Hibbs is selling about 35K shares per week but it should slow down since the price is now lower than what she gets them for. 42 cents

She only has like 115K left before they reload to feed themselves more shares
👍️0
Monksdream Monksdream 10 meses hace
ME new 52 lo
👍️0
ErnieBilco ErnieBilco 11 meses hace
Didn't like it in the .60 and see even less to like at .44 -

I have only one question - Will it be a quick BK or a slow drawn out worthless attempt to infuse some sort of actual value?
👍️0
Monksdream Monksdream 11 meses hace
ME new 52 week low
👍️0
ErnieBilco ErnieBilco 12 meses hace
Hey I'm a gambler but I'm not willing to put any money into this. The Q reads like a failing business venture to me. I saw absolutely no bright spots in the filing. It was worth a look to save my funds from devastating losses.
👍️0
Afterhoursearnings3 Afterhoursearnings3 1 año hace
Grabbed a butt load at .8
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/ME
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/ME
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/ME
👍️0
Afterhoursearnings3 Afterhoursearnings3 1 año hace
Buyside bias last 5 sessions. Will pop
👍️0
Monksdream Monksdream 1 año hace
ME new 52 week low
👍️0
Monksdream Monksdream 1 año hace
ME new 52 week low
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/ME
👍️0
Monksdream Monksdream 1 año hace
ME new 52 week low
👍️0
Monksdream Monksdream 1 año hace
ME new 52 week low
👍️0
Awl416 Awl416 1 año hace
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
👍️0
Afterhoursearnings3 Afterhoursearnings3 1 año hace
Hammer bottom
👍️0
Monksdream Monksdream 1 año hace
ME new 52 Week low
👍️0
Monksdream Monksdream 1 año hace
ME new 52 week low
👍️0
mick mick 1 año hace
ME
23andMe Holding Company
1.51
-0.015 (-0.98%)
Volume: 2,773,867
Day Range: 1.45 - 1.53
Last Trade Time: 7:59:42 PM EDT
👍️0
Monksdream Monksdream 1 año hace
ME new 52 week low
👍️0
Monksdream Monksdream 2 años hace
23andMe Holding Co. NASDAQ: ME

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.
👍️0
propert propert 2 años hace
Great news today, anyone else excited by that green hammer at the close? Let's rock on Monday!
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
1.67
0.04 (2.45%)
Volume: 1,009,450
Day Range: 1.64 - 1.71
Last Trade Time: 7:59:13 PM EDT
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
1.64
0.05 (3.14%)
Volume: 7,698,993
Day Range: 1.57 - 1.65
Last Trade Time: 7:58:30 PM EDT
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
2.07
0.03 (1.47%)
Volume: 4,213,342
Day Range: 1.8338 - 2.10
Last Trade Time: 7:59:16 PM EDT
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
1.99
0.11 (5.85%)
Volume: 1,349,148
Day Range: 1.825 - 1.99
Last Trade Time: 7:36:16 PM EDT
👍️0
Afterhoursearnings3 Afterhoursearnings3 2 años hace
Have 12k shares here now. The data here is extremely valuable.
👍️ 1
mick mick 2 años hace
ME
23andMe Holding Company
2.25
-0.04 (-1.75%)
Volume: 948,040
Day Range: 2.19 - 2.30
Last Trade Time: 7:56:39 PM EDT
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
2.25
-0.04 (-1.75%)
Volume: 948,040
Day Range: 2.19 - 2.30
Last Trade Time: 7:56:39 PM EDT
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
2.51
-0.08 (-3.09%)
Volume: 1,419,788
Day Range: 2.48 - 2.57
Last Trade Time: 7:24:32 PM EST
👍️0
mick mick 2 años hace
ME
23andMe Holding Company
2.59
-0.28 (-9.76%)
Volume: 3,437,659
Day Range: 2.49 - 2.68
Last Trade Time: 6:25:22 PM EST
👍️0

Su Consulta Reciente

Delayed Upgrade Clock